IP Library Granted Patent US 12,494,289
Granted Patent B2
US 12,494,289 · App. 18/460,796 · Granted Dec 9, 2025

Method and diagnostic apparatus for determining enteritis using machine learning model

Inventors: Yo Sep Ji (Suwon-si, KR); So Young Park (Suwon-si, KR)
Assignee: HEM PHARMA INC.
G16H50/20G16B40/00G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,494,289
App. No.
18/460,796
Granted
Dec 9, 2025
Kind
B2
Abstract

A method for determining whether enteritis is present by using a machine learning model may include a process of analyzing a mixture of a gut-derived substance collected from a subject and a gut environment-like composition, a process of extracting multiple microbial data based on an analysis result of the mixture, a process of selecting microbe-related features to be used in the machine learning model from the multiple microbial data based on a predetermined feature selection algorithm, a process of training the machine learning model with the microbe-related features, and a process of inputting, to the trained machine learning model, the microbial data collected from the subject to be tested and determining whether enteritis is present. The microbe-related features may include the amount of one or more microbes selected from genera included in families, Ruminococcaceae, Lactobacillaceae, Prevotellaceae, Barnesiellaceae, Bacteroidaceae, Lachnospiraceae, and UCG.010→Lachnospiraceae, Veillonellaceae, Tannerellaceae, Clostridia, Coriobacteriaceae, Butyricicoccaceae, Streptococcaceae, Bacteroidaceae, UCG.010, Prevotellaceae.

Claims (39)

1 . A method for diagnosing the presence or absence of enteritis by using a machine learning model, comprising:

(a) analyzing a mixture of a gut-derived substance collected from a subject and a gut environment-like composition, the analyzing comprising:

(a-1) culturing the mixture under anaerobic conditions for a period of 18 to 24 hours,

(a-2) centrifuging the cultured mixture to separate a supernatant and a precipitate, and

(a-3) analyzing the supernatant and precipitate;

(b) extracting multiple microbial data based on an analysis result of the mixture;

(c) selecting microbe-related features to be used in the machine learning model from the multiple microbial data based on a predetermined feature selection algorithm;

(d) training the machine learning model with the selected microbe-related features; and

(e) diagnosing whether enteritis is present in a test subject by inputting microbial data from the test subject into the trained machine learning model,

wherein the microbe-related features include an amount of one or more microbes selected from genera included in families, Lachnospiraceae, Veillonellaceae, Tannerellaceae, Clostridia, Coriobacteriaceae, Butyricicoccaceae, Streptococcaceae, Bacteroidaceae, UCG.010, and Prevotellaceae,

wherein the gut environment-like composition includes at least one of sodium chloride (NaCl), sodium carbonate (NaHCO3), potassium chloride (KCl), hemin, or any combination thereof, and

wherein the feature selection algorithm includes at least one of a Boruta algorithm, a recursive feature elimination (RFE) algorithm, or any combination thereof.

2 . The method of claim 1 ,

wherein the number of the microbe-related features to be used in the machine learning model is 11 to 16.

3 . The method of claim 1 ,

wherein the microbial data include at least one of an amount, concentration, or kind of a substance contained in the cultured mixture, or kind, concentration, amount, or diversity changes of bacteria included in microbiota, or any combination thereof and

the substance contained in the cultured mixture includes at least one of endotoxins, hydrogen sulfides, short-chain fatty acids (SCFAs), microbiota-derived metabolites, or any combination thereof.

4 . The method of claim 1 ,

wherein the machine learning model includes at least one of a linear regression analysis (LRA) model, a random forest model, a generalized linear (GLM) model, a gradient boosting model, an extreme gradient boosting (XGB) model, or any combination thereof.

5 . The method of claim 1 ,

wherein the microbe-related features include the amount of one or more microbes selected from species included in genera, Coprococcus, Anaerostipes, Megasphaera, Parabacteroides, Clostridia, Collinsella, Butyricicoccus, Streptococcus, Bacteroides , UCG.010, and Prevotella.

6 . An apparatus for diagnosing the presence or absence of enteritis by using a machine learning model, comprising:

a processor;

a microbial data extraction unit configured to extract multiple microbial data by analyzing a mixture of a gut-derived substance collected from a subject and a gut environment-like composition, the analyzing comprising culturing the mixture under anaerobic conditions for a period of 18 to 24 hours, centrifuging the cultured mixture to separate a supernatant and a precipitate, and analyzing the supernatant and the precipitate;

a feature selection unit configured to select microbe-related features to be used in the machine learning model from the multiple microbial data based on a predetermined feature selection algorithm;

a training unit configured to train the machine learning model with the selected microbe-related features; and

a diagnosis unit configured to input, to the trained machine learning model, microbial data collected from a test subject and diagnose whether enteritis is present in the test subject,

wherein the microbe-related features include the amount of one or more microbes selected from genera included in families, Lachnospiraceae, Veillonellaceae, Tannerellaceae, Clostridia, Coriobacteriaceae, Butyricicoccaceae, Streptococcaceae, Bacteroidaceae, UCG.010, and Prevotellaceae,

wherein the gut environment-like composition includes sodium chloride (NaCl), sodium carbonate (NaHCO3), potassium chloride (KCl), hemin, or any combination thereof, and

wherein the feature selection algorithm includes at least one of a Boruta algorithm, a recursive feature elimination (RFE) algorithm, or any combination thereof.

7 . The apparatus of claim 6 ,

wherein the number of the microbe-related features to be used in the machine learning model is 11 to 16.

8 . The apparatus of claim 6 ,

wherein the microbial data include at least one of an amount, concentration, or kind of a substance contained in the cultured mixture, or kind, concentration, amount, or diversity changes of bacteria included in microbiota, or any combination thereof and

the substance contained in the cultured mixture includes at least one of endotoxins, hydrogen sulfides, short-chain fatty acids (SCFAs), microbiota-derived metabolites, or any combination thereof.

9 . The apparatus of claim 6 ,

wherein the machine learning model includes at least one of a linear regression analysis (LRA) model, a random forest model, a generalized linear (GLM) model, a gradient boosting model, an extreme gradient boosting (XGB) model, or any combination thereof.

10 . The apparatus of claim 6 ,

wherein the microbe-related features include the amount of one or more microbes selected from species included in genera, Coprococcus, Anaerostipes, Megasphaera, Parabacteroides, Clostridia, Collinsella, Butyricicoccus, Streptococcus, Bacteroides , UCG.010, and Prevotella.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2023
From: JI, YO SEP; PARK, SO YOUNG
To: HEM PHARMA INC.
Reel/Frame 064792/0091 →
Priority Claims (1)
KR 10-2021-0039433 · Mar 26, 2021 · national
Continuity (2)
Continuation PCTKR2022003980 · Mar 22, 2022
Related Publication 20230411015A1 · Dec 21, 2023
References Cited (31)
US 11139063B1 · Neumann · 2021 [cited by examiner]
US 11908586B2 · Gippetti · 2024 [cited by examiner]
US 20120149584A1 · Olle · 2012 [cited by examiner]
US 20170228514A1 · Apte et al. · 2017 [cited by applicant]
US 20170367640A1 · Apte · 2017 [cited by examiner]
US 20180342323A1 · Shankar · 2018 [cited by examiner]
US 20190023751A1 · Brown · 2019 [cited by examiner]
US 20200181674A1 · Smith · 2020 [cited by examiner]
US 20200281991A1 · Gerardin · 2020 [cited by examiner]
US 20210233615A1 · Banavar · 2021 [cited by examiner]
US 20210296000A1 · Shaw · 2021 [cited by examiner]
US 20220275112A1 · Cheng · 2022 [cited by examiner]
US 20220293275A1 · Oh · 2022 [cited by examiner]
KR 102057047B1 · 2019 [cited by applicant]
KR 102103281B1 · 2020 [cited by applicant]
KR 1020200054203A · 2020 [cited by applicant]
KR 102103280B1 · 2020 [cited by applicant]
KR 102151497B1 · 2020 [cited by applicant]
KR 102373886B1 · 2022 [cited by applicant]
KR 102373888B1 · 2022 [cited by applicant]
WO 2014121298A2 · 2014 [cited by applicant]
WO WO2017156431A1 · 2017 [cited by examiner]
WO WO2021163637A1 · 2021 [cited by examiner]
Lapidot, American Society For Microbiology, 2020, pp. 1-12 (Year: 2020). [cited by examiner]
B. Wingfield, S. Coleman, T. McGinnity and A. Bjourson, “Robust Microbial Markers for Non-Invasive Inflammatory Bowel Disease Identification,” in IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 1… [cited by examiner]
Jacobson, 2018, Elsevier, pp. 296-307 (Year: 2018). [cited by examiner]
Biswas, Elsevier, 2012, pp. 14-24 (Year: 2012). [cited by examiner]
Westfall S, Carracci F, Estill M, Zhao D, Wu QL, Shen L, Simon J, Pasinetti GM. Optimization of probiotic therapeutics using machine learning in an artificial human gastrointestinal tract. Sci Rep. Jan. 13, 2021;11(1): … [cited by examiner]
Shima H, Masuda S, Date Y, Shino A, Tsuboi Y, Kajikawa M, Inoue Y, Kanamoto T, Kikuchi J. Exploring the Impact of Food on the Gut Ecosystem Based on the Combination of Machine Learning and Network Visualization. Nutrien… [cited by examiner]
Masahiro Sato, et al., Mutually Beneficial Symbiosis Between Human and Gut-Dominant Bacteroides Species Through Bacterial Assimilation of Host Mucosubstances. Laboratory of Basic and Applied Molecular Biotechnology, Div… [cited by applicant]
Wylensek, D., Hitch, T.C.A., Riedel, T et al. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nat Commun 11, 6389 (2020). [cited by applicant]